Lastly, studies exploring the effect of P-MAPA and CIS on genetic TLR2 and TLR4 knockout mouse models of OC are needed to better understand the molecular mechanism(s) by which these therapies effectively promote their immunomodulatory effects in OC. Here, TLR2 is linked to in situ carcinoma.